VARUN M

Clinical Fellow | Salford Royal NHS | @SRIHER_Official Alumnus l @NSMCInternship Co 2021 l @ISB_Healthcare APMH Co 2022

[VARUN M @varunnephro]

“Silicon isn’t just for computers. It can make a pretty good kidney, too” @WIRED

#NephMadness 💪 contender in the #ArtificialKidney region

💥The device incorporated with silicon nanotechnology & tissue engineering - Let’s talk about The Implantable Bioartificial Kidney #NSMC

[Ola M Suliman @justsomebowdaii]

Team @SalfordRenal @ #UKKW26

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

I have been drafting my dream AI-powered nephrology outpatient clinical workflow 🩺📈 and would love to share my thoughts 😊🤔

Discussion more on @ASNKidney AI forum
https://t.co/2L1KebEBny

As shown in the table, AI tools support each phase of the outpatient nephrology workflow:

Pre-visit, AI synthesizes EHR data 📋🤖 to highlight recent hospitalizations, medication changes, and abnormal labs. Risk models 🚩 prioritize high-acuity patients, while NLP triage identifies urgent referral reasons—ensuring a focused visit.

During the visit 🧑‍⚕️👩‍⚕️, ambient scribes and NLP tools 📝 reduce clerical burden, enhancing patient interaction. Decision-support systems integrate real-time data to guide evidence-based care 💊🧬, flag care gaps, and suggest personalized plans 📚✅.

Post-visit, AI monitors results and messages 📲🔁, triggering alerts for clinical deterioration. Home monitoring and AI inbox triage improve follow-up, reduce delays, and minimize unnecessary visits 🌐❤️‍🩹. @MayoClinicNeph

[Nephrology Journal Club @NephJC]

1/10
Last #NephJC we discussed the combination therapy of empagliflozin and finerenone 💊 #TenPostNephJC

🌵From a therapeutic dessert to a flood of options in DKD - what is the best timing to keep the kidneys afloat

[Hannah O'Keeffe @H_okeeffe]

Delighted to see our work from our advanced kidney care service published

@IbrahimZeal1990 @rdonne10 @NCAresearchNHS

[Int Society of Nephrology @ISNkidneycare]

DAPA-Tolvaptan: First trial of SGLT2 inhibition in ADPKD with background tolvaptan therapy @KIReports made it to the #TOM in this #ISNGTF May issue. See the latest #ISNGTF summary for details. VA by @md_abdulqader83

[NDT @NDTsocial]

GLP-1-based therapeutics for cardiorenal protection in metabolic diseases

🆓https://t.co/mkaYlar2I5

[NCA Research NHS @NCAresearchNHS]

Delighted to see so many of our @salfordrenal colleagues speaking at #UKKW2025 inc @SmeetaSinha @hurstnellibert @tinachrysochou Tom McDonnell, Phil Kalra, Darren Green, Saif Al-Chalabi

[Ola M Suliman @justsomebowdaii]

Team @SalfordRenal at #UKKW25

[ERA - European Renal Association @ERAkidney]

🧵1/10
📢 New Definition in Nephrology
Disease-Modifying Anti-Nephropathic Drugs (DMANDs) – A definition proposed by Immunonephrology Working Group (IWG) of the European Renal Association (ERA).
Why does this matter? Let’s break it down!
🔗 https://t.co/rz8ps0HIPY @NDTsocial
An @ERAkidney e-seminar by @ykoteng_LUMC moderators @willkidney and Dr Parminder Judge, panelist @AKronbichler

[ERA - European Renal Association @ERAkidney]

First in Novel CKD Treatments Beyond the Pillars (room K), Jonathan Barratt presenting

🥁Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart

Zigakibart= humanized MAb that blocks APRIL, a soluble factor whose blood level is elevated in patients with IgAN.

#era25 6/

[ERA - European Renal Association @ERAkidney]

💥 Game Changers in CKD and T2DM

💥 first up Peter Rossing on GLP1s

▶️Early CV studies suggested kidney benefits of GLP1s

▶️Flow trial designed to look at kidney outcomes in DKD

💥 Showed improvement in composite kidney outcomes, eGFR slope, cardiovascular outcomes and all cause mortality.

💥💥 NNT only 20 for composite kidney outcomes when treated for 3 years

💥 Outcomes similar if already on SGLT2 (15%)or on MRA ( 7%) -▶️ benefits additive!

💥More to come- tirzepatide also showing big effects and more trials on the way

💥💥Exciting times! 💥💥

- Sarah Gleeson

[ERA - European Renal Association @ERAkidney]

#ERA25 #BeyondNephrology
1/And now one of the most awaited sessions in Late Breaking Clinical Trials 1: Cutting-Edge Clinical Trials in #Nephrology🥁

🚨 THE CONFIDENCE TRIAL: EFFICACY/SAFETY OF COMBINING FINERENONE WITH EMPAGLIFLOZIN IN PEOPLE WITH CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETES

👤Rajiv Agarwal
✖️@AgarwalRajivMD

👤 Peter Rossing
✖️@P_Rossing

👤 Hiddo J.L. Heerspink
✖️@HeerspinkHiddo

👤 Johannes F.E. Mann

[NEJM @NEJM]

Presented at #ERA25:

In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: https://t.co/4Gf0LboOCp

@ERAkidney

[The Heart @ZHeart11768530]

🔴Approach to Resistant Hypertension⤵️ #2024Review #OpenAccess

🔹https://t.co/9PfhjSVlwe
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd

[AINU Nephrology @AinuNephrology]

@AINUKidneyRun
"Optimising prescription practises"

This #WorldKidneyDay AINU team promotes best prescription practises for optimal outcomes..

Creating awareness by annual running event..

[𝘿𝙚𝙚𝙥𝙖𝙠 𝙍𝙖𝙜𝙤𝙤𝙧𝙞 @drragoori]

4th edition of @AINUKidneyRun held on the eve of @worldkidneyday was a huge success with over 1500 runners showing their support to spread awareness in kidney health ! @KomatireddyKVR garu flagged off the run 🏃‍♀️🙏🏻 @360lifeEL @MercedesBenzInd Mahavir motors Thank you 🙏🏻

[Dr P S Vali @DrPSVali]

✨ Embracing luminous traditions, the #TransplantConclave 🌟 begins with a vibrant inauguration.
Dr MV Rao sir gave inspiring opening remarks.
Program director @srikanthnephro addressed the distinguished audience

@ainuindia @ainunephrology

[Asian Institute of Nephrology and Urology @ainuindia]

AINU Transplant Conclave in association with @HydNephForum ! Join us to see the experts comment and deliberate on various topics on 13th and 14th May @Hyatt Place, Hyderabad @AinuNephrology @isn_india @ISNkidneycare @srikanthnephro @DrPSVali @dakidneydoc @varunnephro @navinath_m

[AINU Nephrology @AinuNephrology]

Thanks for the overwhelming response to the #AINUKidneyrun Honoured to have the stalwarts in Nephrology participating🙏🙏🙏 @SwarnalathaGud2 @drmanishasahay @DrPSVali #WorldKidneyDay @srikanthnephro @varunnephro @sujeethbande @kranthi_nephro

[Edgar V. Lerma 🇵🇭 @edgarvlermamd]

Hey #Nephpearls followers

#NephMadness 2️⃣🏀2️⃣3️⃣ is upon us‼️

LIKE ❤️ If this is the first time you’ve heard about it (if so, please click on link)

RETWEET 🔄 If you’re going to participate

Link 👉🏼 https://t.co/7LQc7TMBK1 via @AJKDonline